GB Patent

GB2447949B — A method for identifying a compound for treating a disorder or condition associated with dysfunction of monoamine neurotransmission

Assigned to RENASCI CONSULTANCY Ltd · Expires 2010-03-31 · 16y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: GB2447949B
Jurisdiction: GB
Classification: —
Expires: 2010-03-31
Drug substance claim: No
Drug product claim: No
Assignee: RENASCI CONSULTANCY Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.